Developer docs
API playgroundTry for free, no card

Search company profiles

Testa Center

Full company profile

uuid0028ned

Namestring
Testa Center
Legal namestring
Testa Center
Websiteurl
testacenter.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Testa Center is a non-profit, non-GMP pilot-scale bioprocessing testbed located in Uppsala, Sweden, inaugurated in August 2018 as a public-private initiative between the Swedish government and Cytiva (which wholly owns the entity). The facility provides industry, academia, and startups with access to industrial-scale bioprocessing equipment up to 500 liters at biosafety level 2, supporting upstream processing (stirred-tank and rocking-motion bioreactors), midstream techniques (normal flow filtration, tangential flow filtration, centrifugation), and downstream protein purification. It also runs a dedicated Technology and Digital Innovation Services line for validating sensors, automation, and digital tools in a real bioproduction environment.

The company monetizes primarily through usage-based facility access fees (100,000 SEK per week for academic projects), training and education services, and the annual Testa Challenge program, which is a fully funded three-week open-innovation program co-financed by Region Uppsala and the EU Regional Development Fund via Tillv\u00e4xtverket. A separate Testa Center Access Grant covers the access fee for eligible academic projects. Customers are SMEs, biotech and pharmaceutical companies, academic institutions, and technology/digital startups; named users include Ilya Pharma, BioLamina, Lokon Pharma, Toleranzia, Analysis Mode, Nyctea Technologies, CEIDOS, IRUBIS, and Nanolyze, alongside Uppsala University students.

Operationally, Testa Center runs with a small core team of approximately nine specialists covering upstream, downstream, IT/digital, customer relations, and facility management, and benefits from close partnerships with Cytiva (equipment and strategic direction), Uppsala University (research and education), STUNS Life Science (ecosystem coordination), and a roster of technology and financial partners including Aldevron, Pall Biotech, RISE, Gyros Protein Technologies, Knightec, Xertified, Vinnova, and Swelife. Its go-to-market is consultative and project-based: prospective customers apply or are invited, undergo feasibility evaluation, then access the facility.

Short descriptiontext

Testa Center is a non-profit, non-GMP pilot-scale bioprocessing testbed in Uppsala, Sweden, wholly owned by Cytiva. It serves biotech SMEs, pharma, academic institutions, and tech startups by providing up-to-500L bioreactor access, process scale-up support, and digital innovation validation services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersUppsala, Sweden
HQ citystring
Uppsala
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioprocessing testbed services, pilot-scale biological production, biopharmaceutical scale-up, bioprocess innovation verification, non-GMP manufacturing facility
Product category
Bioprocessing Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Facility access fees
TypeUsage Based
Description

Testa Center charges an access fee of 100,000 SEK per week for academic projects to use the bioprocessing facility. Commercial projects are also charged for access. The grant program (Testa Center Access Grant) can cover the access fee for eligible academic projects.

testacenter.com
2Training and education services
TypeProfessional Services
Description

Testa Center provides hands-on training programs, webinars, and educational activities for students and professionals in biological production, including master student projects, remote training, and specialized workshops.

testacenter.com
3Testa Challenge program
TypeSubscription Recurring
Description

A fully funded three-week open innovation challenge for tech/digital/data innovators, funded by Region Uppsala and the European regional development fund (ERDF) via Tillväxtverket. Aldevron supplies production-grade plasmid DNA to participants.

testacenter.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales
Pricing details2 tiers
1Academic access grant — covers facility access fee
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Access fee: 100,000 SEK/week. Grant can cover up to 5 weeks. Applicant must cover consumables and personnel costs in addition.

testacenter.com
2Standard commercial access — facility use fee
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Commercial users are charged a facility access fee. No public pricing listed; likely quote-based for custom projects.

testacenter.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Testa Challenge
Description

A fully funded three-week program where tech, digital, or data innovators can test their technologies in an industry-standard bioprocess at Testa Center.

aldevron.com
Core offering1 text field

Testa Center operates a non-GMP, biosafety-level-2 pilot-scale bioprocessing testbed in Uppsala, Sweden, where companies, academic institutions, and startups run upstream, midstream, and downstream biological production projects using Cytiva-supplied industrial equipment up to 500L. The facility also provides hands-on training, technological and digital innovation verification, and runs the Testa Challenge open-innovation program and the Testa Center Access Grant for academic projects.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 15 projects from Scandinavia completed in first year of operation
+4 more records
Product overview1 text field

Testa Center is an open-access bioprocessing testbed facility in Uppsala, Sweden, operated as a public-private initiative between the Swedish government and Cytiva. The facility offers three integrated service lines: Biological Production Services (for scaling up and industrializing bioprocesses including upstream, midstream, and downstream processing), Technological and Digital Innovation Services (for verifying tech/digital innovations in real production environments), and Training & Education (for hands-on skill development). The flagship Testa Challenge program enables technology companies to validate innovations in a funded three-week biomanufacturing 'hackathon' environment. Additional offerings include the Access Grant program for academic institutions and comprehensive equipment access spanning bioreactors, purification systems, analytic instruments, and cell/gene therapy tools up to 500L scale (non-GMP, up to Biosafety Level 2).

Product and service5 records
1Biological Production Services
CategoryBioprocessing Services
Description

Industrial-scale bioprocessing services enabling companies and academia to scale up biological production, secure scalability, manufacturability, and robustness while retaining intellectual property. Services include upstream processing (cell culture in stirred-tank and rocking-motion bioreactors), midstream techniques (NFF, TFF, centrifugation), and downstream processing (protein purification).

2Technological and Digital Innovation Services
CategoryBioprocessing Services
Description

Support for digital transformation in bioprocessing, including verification of technological and digital products and services in a real-world production environment. Enables validation of sensors, automation solutions, digital twins, process modeling, and control systems for biopharma and life-science buyers.

3Training & Education
CategoryEducation and Training Services
Description

Hands-on practical training programs for academia and industry professionals, providing experience with industrial-scale bioprocessing equipment. Includes student lab exercises, process control training, and remote training capabilities.

4Testa Challenge
CategoryOpen Innovation Program
Description

An open-innovation challenge program enabling tech, digital, and data companies to test and verify their technologies in a fully funded, industry-standard bioproduction workflow. Participants work side-by-side with Testa Center experts for three weeks to gain hands-on proof of concept, with Aldevron supplying production-grade plasmid DNA.

5Testa Center Access Grant
CategoryAccess Grant Program
Description

A grant program for academic institutions providing up to 5 weeks of fully funded access to Testa Center (100,000 SEK/week access fee covered). Supports projects including developing or scaling production processes, testing technical innovations, and educational activities.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Testa Center is a public-private initiative between the Swedish government and Cytiva. Cytiva provides equipment, expertise, and operational support. Testa Center is a non-profit company owned by Cytiva. The partnership aims to secure the growth of the life science industry and its manufacturing capabilities.

2Swedish government (Regeringskansliet)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Swedish government is a co-founding partner in the Testa Center initiative, supporting the development of national infrastructure for biological production and life science industry growth.

testacenter.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-term collaboration agreement with Uppsala University gives researchers and students access to Testa Center equipment and expertise. The university and Cytiva partnership facilitates academic education and joint research projects in bioprocessing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

STUNS (Stiftelsen för samverkan mellan universitet, näringsliv och samhälle) Life Science collaborates with Testa Center on organizing Testa Challenge, ecosystem development, and coordinating the Access Grant evaluation board.

5AdBIOPRO (KTH, Lund University, Cytiva)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

AdBIOPRO is a Swedish competence centre for advanced bioproduction. KTH, Lund University, and Cytiva conducted continuous upstream and downstream bioprocessing research at Testa Center, demonstrating perfusion processes and automated purification at production scale.

testacenter.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Testa Center

Bioprocessing Servicestestacenter.com

Testa Center is a non-profit, non-GMP pilot-scale bioprocessing testbed in Uppsala, Sweden, wholly owned by Cytiva. It serves biotech SMEs, pharma, academic institutions, and tech startups by providing up-to-500L bioreactor access, process scale-up support, and digital innovation validation services.

What Testa Center does

Testa Center is a non-profit, non-GMP pilot-scale bioprocessing testbed located in Uppsala, Sweden, inaugurated in August 2018 as a public-private initiative between the Swedish government and Cytiva (which wholly owns the entity). The facility provides industry, academia, and startups with access to industrial-scale bioprocessing equipment up to 500 liters at biosafety level 2, supporting upstream processing (stirred-tank and rocking-motion bioreactors), midstream techniques (normal flow filtration, tangential flow filtration, centrifugation), and downstream protein purification. It also runs a dedicated Technology and Digital Innovation Services line for validating sensors, automation, and digital tools in a real bioproduction environment.

The company monetizes primarily through usage-based facility access fees (100,000 SEK per week for academic projects), training and education services, and the annual Testa Challenge program, which is a fully funded three-week open-innovation program co-financed by Region Uppsala and the EU Regional Development Fund via Tillv\u00e4xtverket. A separate Testa Center Access Grant covers the access fee for eligible academic projects. Customers are SMEs, biotech and pharmaceutical companies, academic institutions, and technology/digital startups; named users include Ilya Pharma, BioLamina, Lokon Pharma, Toleranzia, Analysis Mode, Nyctea Technologies, CEIDOS, IRUBIS, and Nanolyze, alongside Uppsala University students.

Operationally, Testa Center runs with a small core team of approximately nine specialists covering upstream, downstream, IT/digital, customer relations, and facility management, and benefits from close partnerships with Cytiva (equipment and strategic direction), Uppsala University (research and education), STUNS Life Science (ecosystem coordination), and a roster of technology and financial partners including Aldevron, Pall Biotech, RISE, Gyros Protein Technologies, Knightec, Xertified, Vinnova, and Swelife. Its go-to-market is consultative and project-based: prospective customers apply or are invited, undergo feasibility evaluation, then access the facility.

Testa Center firmographics

Firmographics
Name
Testa Center
Legal name
Testa Center
Website
https://testacenter.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Testa Center is a non-profit, non-GMP pilot-scale bioprocessing testbed in Uppsala, Sweden, wholly owned by Cytiva. It serves biotech SMEs, pharma, academic institutions, and tech startups by providing up-to-500L bioreactor access, process scale-up support, and digital innovation validation services.
Ownership category
akta.pro rank

Where Testa Center is headquartered

Location

Headquarters

HQ city
Uppsala
HQ country
Sweden
HQ region
Europe

Offices2 records

Markets served

Testa Center business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Facility access fees: Testa Center charges an access fee of 100,000 SEK per week for academic projects to use the bioprocessing facility. Commercial projects are also charged for access. The grant program (Testa Center Access Grant) can cover the access fee for eligible academic projects.
  2. Training and education services: Testa Center provides hands-on training programs, webinars, and educational activities for students and professionals in biological production, including master student projects, remote training, and specialized workshops.
  3. Testa Challenge program: A fully funded three-week open innovation challenge for tech/digital/data innovators, funded by Region Uppsala and the European regional development fund (ERDF) via Tillväxtverket. Aldevron supplies production-grade plasmid DNA to participants.

Pricing tiers

ModelBillingPrice
Usage-basedPay-as-you-goAcademic access grant — covers facility access fee
Usage-basedPay-as-you-goStandard commercial access — facility use fee

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Testa Center product offering

Product offering

Core offering

Testa Center operates a non-GMP, biosafety-level-2 pilot-scale bioprocessing testbed in Uppsala, Sweden, where companies, academic institutions, and startups run upstream, midstream, and downstream biological production projects using Cytiva-supplied industrial equipment up to 500L. The facility also provides hands-on training, technological and digital innovation verification, and runs the Testa Challenge open-innovation program and the Testa Center Access Grant for academic projects.

Product overview

Testa Center is an open-access bioprocessing testbed facility in Uppsala, Sweden, operated as a public-private initiative between the Swedish government and Cytiva. The facility offers three integrated service lines: Biological Production Services (for scaling up and industrializing bioprocesses including upstream, midstream, and downstream processing), Technological and Digital Innovation Services (for verifying tech/digital innovations in real production environments), and Training & Education (for hands-on skill development). The flagship Testa Challenge program enables technology companies to validate innovations in a funded three-week biomanufacturing 'hackathon' environment. Additional offerings include the Access Grant program for academic institutions and comprehensive equipment access spanning bioreactors, purification systems, analytic instruments, and cell/gene therapy tools up to 500L scale (non-GMP, up to Biosafety Level 2).

Differentiator

Problem solved

Functional benefit

Brands

  • Testa Challenge: A fully funded three-week program where tech, digital, or data innovators can test their technologies in an industry-standard bioprocess at Testa Center.

Products and services

  • Biological Production Services Industrial-scale bioprocessing services enabling companies and academia to scale up biological production, secure scalability, manufacturability, and robustness while retaining intellectual property. Services include upstream processing (cell culture in stirred-tank and rocking-motion bioreactors), midstream techniques (NFF, TFF, centrifugation), and downstream processing (protein purification).
  • Technological and Digital Innovation Services Support for digital transformation in bioprocessing, including verification of technological and digital products and services in a real-world production environment. Enables validation of sensors, automation solutions, digital twins, process modeling, and control systems for biopharma and life-science buyers.
  • Training & Education Hands-on practical training programs for academia and industry professionals, providing experience with industrial-scale bioprocessing equipment. Includes student lab exercises, process control training, and remote training capabilities.
  • Testa Challenge An open-innovation challenge program enabling tech, digital, and data companies to test and verify their technologies in a fully funded, industry-standard bioproduction workflow. Participants work side-by-side with Testa Center experts for three weeks to gain hands-on proof of concept, with Aldevron supplying production-grade plasmid DNA.
  • Testa Center Access Grant A grant program for academic institutions providing up to 5 weeks of fully funded access to Testa Center (100,000 SEK/week access fee covered). Supports projects including developing or scaling production processes, testing technical innovations, and educational activities.

Quantifiable outcome

  • 15 projects from Scandinavia completed in first year of operation
  • +4 more outcomes

Companies that use Testa Center

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Testa Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Testa Center partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • CytivacoreStrategic or Co-development PartnerTesta Center is a public-private initiative between the Swedish government and Cytiva. Cytiva provides equipment, expertise, and operational support. Testa Center is a non-profit company owned by Cytiva. The partnership aims to secure the growth of the life science industry and its manufacturing capabilities.
  • Swedish government (Regeringskansliet)coreStrategic or Co-development PartnerThe Swedish government is a co-founding partner in the Testa Center initiative, supporting the development of national infrastructure for biological production and life science industry growth.
  • Uppsala UniversitycoreStrategic or Co-development PartnerLong-term collaboration agreement with Uppsala University gives researchers and students access to Testa Center equipment and expertise. The university and Cytiva partnership facilitates academic education and joint research projects in bioprocessing.
  • STUNS Life SciencecoreStrategic or Co-development PartnerSTUNS (Stiftelsen för samverkan mellan universitet, näringsliv och samhälle) Life Science collaborates with Testa Center on organizing Testa Challenge, ecosystem development, and coordinating the Access Grant evaluation board.
  • AdBIOPRO (KTH, Lund University, Cytiva)minorStrategic or Co-development PartnerAdBIOPRO is a Swedish competence centre for advanced bioproduction. KTH, Lund University, and Cytiva conducted continuous upstream and downstream bioprocessing research at Testa Center, demonstrating perfusion processes and automated purification at production scale.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Testa Center competitors and assessment

Company assessment

Market position

Competitive moat5 records

Customer concentration

Testa Center social profiles

Digital presence

Testa Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Testa Center leadership team

Management profile

Number of profiles

Profiles9 records

Testa Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Testa Center M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Testa Center

What does Testa Center do?

Testa Center operates a non-GMP, biosafety-level-2 pilot-scale bioprocessing testbed in Uppsala, Sweden, where companies, academic institutions, and startups run upstream, midstream, and downstream biological production projects using Cytiva-supplied industrial equipment up to 500L. The facility also provides hands-on training, technological and digital innovation verification, and runs the Testa Challenge open-innovation program and the Testa Center Access Grant for academic projects.

Is Testa Center a public or private company?

Testa Center is a private company. It is classified as corporate owned and is currently operating.

When was Testa Center founded?

Testa Center was founded in 2018. It employs 1 to 10 people.

Where is Testa Center based?

Testa Center is headquartered in Uppsala, Sweden, in the Europe region.

How does Testa Center make money?

Three revenue lines are on record. Facility access fees are the primary driver. The others are training and education services and testa Challenge program.

Does Testa Center have an API?

No public API is recorded for Testa Center.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals